A Project Report On “The Analysis of Financial Statement with the help of Ratio Analysis Techniques” For Sangamner Taluka Sahakari Dudh Utpadak & Prakriya Sangh Ltd‚ Sangamner‚ Tal. Sangamner‚ Dist. A’Nagar. Submitted to UNIVERSITY OF PUNE IN PARTIAL FULFILLMENT OF MASTER OF BUSINESS ADMINISTRATION (MBA) (2010-2012) By Ramesh Chandrabhan Hase (Finance) Under The Guidance Of Prof. Anil Bendre Abhinav Education Society’ INSTITUTE OF MANAGEMENT AND BUSINESS ADMINISTRATION Akole
Premium Milk
Mini Case : Ratios And Financial Planning At East Coast Yachts 1. Calculate all of the ratios listed in the industry table for East Cost Yachts. Ratios Calculation 2009 a) Current Ratio 0.75 b) Quick Ratio 0.44 c) Total Asset Turnover 1.54 d) Inventory Turnover 19.22 e) Receivables Turnover 30.57 f) Debt Ratio 0.49 g) Debt to Equity Ratio
Premium Generally Accepted Accounting Principles Balance sheet Financial ratios
Current Ratio Interpretation From the calculation of the current ratio it is evident that the company’s current ratio for the year 2010 is 1.30:1 ‚2011 is 1.80:1‚ 2012 is 1.54:1 and 2013 is a 1‚53:1‚ that is company’s current assets in year 2013 was Rs. 1.53 for every 1Re of current liability‚ while in the year 2012 the current asset was Rs 1.54 Re of its current liability‚ while in the year 2011 the current assets was Rs 1.80 Re of its current liability‚ and while in the year 2010 the
Premium Generally Accepted Accounting Principles Asset Balance sheet
Comparison of the two Great Awakenings The Great Awakening and the Second Awakening were less of a rebellion and more of a mind shift for Christians. These two events caused people to rely on their faith. In previous centuries people relied on their religion. The two Awakenings were similar in their goals but very different in the way they came about and the individual tasks that were accomplished. The first movement‚ the Great Awakening‚ was focused on people. In the past preachers
Premium
Ratio analysis Track software‚Inc. ------------------------------------------------- Actual industy Average TS:Time series Ratio 2008 2009 2009 CS:Cross sectional | | | | Net working $21000capital | $58000 | $96000 | TS:ImprovingCS:Poor | Current 1.06 ratio | 1.16 | 1.82 | TS:ImprovingCS:Poor | Quick 0.63ratio | 0.63 | 1.10 | TS:ImprovingCS:Poor | Inventory 10.40Turnover
Premium Financial ratio Financial ratios Asset
Incumbent Company: Dr. Reddy’s Laboratories ¬¬¬ Indian Pharmaceutical Industry can be valued at around $20billion (2009). By Volume‚ India is world’s second largest producer of pharmaceuticals‚ while by value it is world’s thirteenth largest. It is expected to grow at CAGR of 12% for 2010-2012 (global average 6%).Around 95% of Domestic demand is catered by Indian Pharmaceutical companies. In Indian Pharmaceuticals Market‚ Formulations accounted for 65% while Bulk Drugs accounted for 35% by
Premium Generic drug Pharmaceutical industry Pharmacology
Ratio Analysis Memo July 9‚ 2012 Memo To: From: Date: July 9‚ 2012 RE: Kudler Fine Foods ratio analysis One of the things that we will be going over is some of the ratios for Kudler Fine Foods through Liquidity‚ Profitability‚ and solvency ratios. We will look into some of the finding that were found through these ratios and discuss them. One of the things that we found was where Kudler Fine Foods’ position is with these ratios. The first area that we look at is profitability
Premium Balance sheet Asset Generally Accepted Accounting Principles
Current Ratio 2012 (‘000) 2013 (‘000) (Current Asset)/(Current Liabilities) (Current Asset )/( Current Liabilities) = (RM 308‚510)/RM161‚786 = RM337‚728/(RM 222‚768) = 1.91 : 1 = 1.52 : 1 The table above shows that Dutch Lady has a decreased
Premium Balance sheet Asset Inventory
Lecturer: Shrimal Perera Sigma Pharmaceuticals Limited‚ 96 Merrindale Drive South Croydon‚ VIC‚ 3136 Australia Mr. Shrimal Perera Lecturer‚ Monash University 900 Dandenong Road Caulfield East VIC 3145 Dear Shrimal‚ Attached is the report you requested on for the 19th of May
Premium Management Finance Business
IBUS 3312 - International Management Pharmaceutical Companies‚ Intellectual Property‚ and the Global AIDS Epidemic Analysis While this case is literally full of negative aspects‚ we will only focus on the main points for both arguments. Pharmaceutical companies want to be sure that the products they spend years and millions of dollars to create are not easily reproduced and sold at discount prices. The profits pharmaceuticals make of their patented products are supposed to refinance
Premium United Nations AIDS Developing country